✦ LIBER ✦

Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial

✍ Scribed by Parvanova, Aneliya; van der Meer, Irene M; Iliev, Ilian; Perna, Annalisa; Gaspari, Flavio; Trevisan, Roberto; Bossi, Antonio; Remuzzi, Giuseppe; Benigni, Ariela; Ruggenenti, Piero

Book ID: 120435933
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 289 KB
Volume: 1
Category: Article
ISSN: 2213-8587
DOI: 10.1016/S2213-8587(13)70029-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of dapagliflozin in patients with

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

✍ Clifford J Bailey; Jorge L Gross; Anne Pieters; Arnaud Bastien; James F List 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 260 KB

Effect of cilostazol on arterial stiffne

Effect of cilostazol on arterial stiffness and vascular adhesion molecules in type 2 diabetic patients with metabolic syndrome: a randomised, double-blind, placebo-controlled, crossover trial

✍ Kim, Nam; Kim, Hee; An, Hyonggin; Seo, Ji A; Kim, Nan; Choi, Kyung; Baik, Sei; C 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 216 KB

Effect of dapagliflozin in patients with

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial

✍ K. Strojek; K. H. Yoon; V. Hruba; M. Elze; A. M. Langkilde; S. Parikh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

Effects of once-daily teneligliptin on 2

Effects of once-daily teneligliptin on 24-h blood glucose control and safety in Japanese patients with type 2 diabetes mellitus: a 4-week, randomized, double-blind, placebo-controlled trial

✍ T. Eto; S. Inoue; T. Kadowaki 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

Trial finds low dose ramipril does not r

Trial finds low dose ramipril does not reduce cardiovascular or renal events in people with type 2 diabetes and albuminuria: Abstracted from: Marre M, Lievre M, Chatellier G, et al. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ 2004; 328(7438): 495–500.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 125 KB